Anne Wojcicki's nonprofit, TTAM Research Institute, has received court approval to buy 23andMe — the genetic testing company ...

A bankruptcy court this week approved the $305 million sale of genetics testing firm 23andMe to a nonprofit organization led ...

The DNA data of millions of people who used 23andMe's services won't be sold to a pharmaceutical company. A bankruptcy judge ...

Anne Wojcicki's winning bid to reclaim control of 23andMe doesn't necessarily end the fight over what happens to the DNA of 15 million people collected by the bankrupt consumer genomics company.

Bankrupt genetic analysis company 23andMe will hold a second auction for its cache of DNA data with an opening bid of $305 million from a group led by the company’s former chief executive ...

Regeneron is trying to buy 23andMe – and by extension, your DNA information | Opinion As 23andMe’s sale proceeds, the public must remain vigilant.

Regeneron Pharmaceuticals has announced it will acquire 23andMe, the once high-flying consumer DNA testing company, for $256 million through a bankruptcy auction.The deal comes after 23andMe filed ...

Biotech giant Regeneron announced Monday that it would acquire DNA testing company 23andMe for $256 million following a bankruptcy auction. The deal includes access to 23andMe's massive personal ...

Well, now that 23andMe will have a new parent, does that mean the data will be in safer hands? In its press release, Regeneron touted its expertise in biotechnology and DNA research and promised ...

Bankrupt genetic-testing firm 23andMe agreed to sell its data bank, which once contained DNA samples from about 15 million people, to the drug developer Regeneron Pharmaceuticals for $256 million.

A company representative shows off what is in a 23andMe DNA kit. Regeneron said it will comply with 23andMe's privacy policies with respect to customer data. (George Frey/Reuters) ...